May 7, 2026 04:43PM
Mar 25, 2026 04:22PM
Jan 9, 2026 07:14AM
Nov 5, 2025 07:00AM
Jul 7, 2025 09:48AM
Jun 24, 2025 03:50PM
Jun 16, 2025 07:28AM Stifel Reiterates Buy Rating on Kalvista Pharmaceuticals Inc (KALV)
Mar 26, 2025 06:57AM
Nov 12, 2024 06:30AM
Nov 4, 2024 07:06AM
Nov 4, 2024 07:05AM
Jul 11, 2024 06:30AM
May 21, 2024 06:30AM
Feb 15, 2024 06:31AM KalVista Pharmaceuticals (KALV) Prices $160.1M Offering at $15.25/sh
Feb 15, 2024 06:30AM
Feb 14, 2024 04:19PM
Feb 14, 2024 04:18PM
Dec 7, 2023 06:30AM
Nov 7, 2023 06:30AM
Sep 7, 2023 06:30AM
May 23, 2023 06:30AM KalVista Pharmaceuticals to Present at Stifel 2023 Tailoring Genes: Genetic Medicines Day Virtual Conference
Dec 8, 2022 06:30AM
Nov 7, 2022 06:45AM
Jun 7, 2022 05:05PM
Nov 9, 2021 07:00AM
Feb 16, 2021 04:01PM
Feb 11, 2021 05:57AM
Feb 10, 2021 09:52PM KalVista Pharmaceuticals Announces Pricing of an Upsized $193.5 Million Public Offering of Common Stock
Feb 9, 2021 04:02PM
Feb 9, 2021 04:01PM
Feb 9, 2021 09:55AM
Nov 9, 2020 07:00AM
Nov 13, 2019 07:30AM
Nov 6, 2018 07:30AM
Oct 15, 2018 04:46AM Stifel Starts Kalvista Pharmaceuticals Inc (KALV) at Buy
Sep 10, 2018 04:01PM
Sep 6, 2018 09:17AM
Sep 6, 2018 09:15AM
Sep 5, 2018 04:03PM
Sep 5, 2018 04:02PM
Nov 8, 2017 07:30AM
Oct 17, 2017 09:24AM Pre-Open Movers 10/17: (SNCR) (EYES) (IMDZ) Higher; (BMI) (IPXL) (HOG) Lower (more...)

42,862 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All